The World Health Organization releases updated guidelines for the treatment of drug-susceptible TB and patient care.

The prevalence of mental disorders among people with TB is estimated to be between 40-70%.

The World Health Organization (WHO) recommends the use of a next-generation Xpert® MTB/RIF assay (called Xpert® MTB/RIF Ultra) as a replacement for the current Xpert MTB/RIF® cartridge.

World TB Day 2017 – Unite efforts to leave no one behind

The conditional recommendation will be maintained until a new systematic review of evidence is warranted or the results of the phase III clinical trial of bedaquiline become available.

28 February 2017 | GENEVA - WHO reaffirms the critical need for research and development (R&D) of new antibiotics to tackle the threat of drug-resistant tuberculosis (TB).

27 February 2017 | GENEVA - WHO today published its first ever list of antibiotic-resistant "priority pathogens" – a catalogue of 12 families of bacteria that pose the greatest threat to human health.

The World Health Organization (WHO) is currently developing new guidelines on the management of latent TB infection. The issues covered by the guidelines will include provision of TB preventive treatment for people living with HIV and people who were exposed to a person with active TB disease at home and regimen of preventive TB treatment. 

Geneva, 21 December  2016 - In an effort to accelerate progress towards ending TB, WHO’s Global TB Programme (GTB)  has established the first Global TB Research Task Force.

The World Health Organization (WHO) is seeking a paediatrician with expertise in childhood tuberculosis (TB) for Liberia to facilitate (i) review of diagnostic practices in-country and confirmation of diagnostic algorithms; (ii) development of training materials on childhood TB and (iii) indicators for childhood TB case findings, treatment success and preventive chemotherapy (IPT) with annual targets up to 2020.